Medistim ASA (STU:MD1) FFO


STU:MD1 Medistim ASA STU:MD1
96 GF Score
Price €20.10
GF Value €22.51
! 1 Warning Sign
View Full Analysis

What is Medistim ASA FFO?

FFO (Funds from operations) only applies to REITs.

STU:MD1
96GF Score
Medistim ASA STU:MD1
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medistim ASA (STU:MD1) Overvalued in 2026?

Based on GuruFocus' analysis, Medistim ASA stock appears to be undervalued. The current stock price of €20.10 is trading 10.7% below its estimated GF Value™ of €22.51.

Key valuation signals for STU:MD1:

  • FFO:
  • GF Value™: €22.51 vs. price of €20.10 (10.7% below fair value)
  • GF Score™: 96/100 with 1 warning sign

No single metric tells the full story. See the STU:MD1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medistim ASA Business Description

Address Okernveien 94, Oslo, NOR, 0579
Medistim ASA is a medical device company. It is engaged in researching, developing, producing, distributing, and sales of medical equipment through its own business or participation in other companies, as well as related activities. The company's business is focused on cardiac and vascular surgery. The group operates in the USA, Europe, China, and the Rest of the World. The main divisions are sale of own products and sale of third-party products. Sale of own products has two business models, the capital model and the lease model. Third-party products segment sells medical devices from third party manufacturers in Norway, Sweden and Denmark. Key revenue is generated from Own Products segment.
96GF Score

Get the complete analysis for STU:MD1

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.10
Price
€22.51
GF Value